Upgrading Your Health: Navigating AI's Future In Healthcare with John Halamka of Mayo Clinic Platform
Gradient Dissent: Conversations on AIShow Notes
In the newest episode of Gradient Dissent, we explore the intersecting worlds of AI and Healthcare with John Halamka, President of the Mayo Clinic Platform. Journey with us down John Halamka's remarkable path from his early tech startup days to leading innovations as the President of the Mayo Clinic Platform, one of the world's most esteemed healthcare institutions. This deep dive into AI's role in modern medicine covers the technology's evolution, its potential to redefine patient care, and the visionary work of Mayo Clinic Platform in harnessing AI responsibly. Explore the misconceptions surrounding AI in healthcare and discover the ethical and regulatory frameworks guiding its application. Glimpse into the future with Halamka's visionary perspective on AI's potential to democratize and revolutionize healthcare across the globe. Join us for an enlightening discussion on the challenges, triumphs, and the horizon of AI in healthcare through the lens of John Halamka's pioneering experiences. 🎙 Get our podcasts on these platforms: Apple Podcasts: http://wandb.me/apple-podcasts Spotify: http://wandb.me/spotify Google: http://wandb.me/gd_google YouTube: http://wandb.me/youtube ✅ Follow Weights & Biases: https://twitter.com/weights_biases https://www.linkedin.com/company/wandb
More from Gradient Dissent: Conversations on AI
Can today's power grid handle the explosive growth of AI data centers? Tesla Alum Drew Baglino, now founder & CEO of Heron Power, doesn't think so.
Should American companies be worried about Chinese open-source AI models?
"We are going to switch from the problem in AI being that nothing works to the problem being that everything works."
Samuel Rodriques left physics because there were no unsolved problems left. Instead, he built an AI scientist named Kosmos to cure every disease, solve aging, and map the human brain. In this episode: The cure his AI proposed for blindness Why he would never touch a peptide Whether we'll need human scientists in 20 years What's stopping America in drug discovery
"Every vehicle is capable of driverless operation. That's clearly the steady state of where we're going." Wayve started in a rented house in Cambridge with $1.5M, a car in the garage, and an aim to integrate end-to-end AI into driving. A decade later it's driven across 506 cities without a single HD map and is worth over $8.6 billion. In this episode, CEO Alex Kendall joins Lukas Biewald to talk about how he built the AI driver Uber, Nvidia, Mercedes, and Nissan all backed, and why putting self-driving AI into 100 million cars a year is a far bigger bet than 10,000 robotaxis. Waymo and Tesla both come up. He doesn't shy away.